Summer Savings! Get unlimited digital access for 13 weeks for $13.


Obama policies could stifle Md.'s biotech industry

The Food and Drug Administration's plans to streamline the approval process for "breakthrough" drugs that treat life-threatening diseases is great news for patients and has enormous potential for our pharmaceutical industry, already in the midst of an innovation explosion. Unfortunately, in the middle of all this progress, political leaders in Washington are pushing proposals that would severely undermine innovation and deliver a crippling blow to Maryland's biotech industry. Lawmakers must understand that without a favorable policy environment, innovation can grind to a halt. As the understanding of diseases has vastly expanded, so too has our ability to manage,...